Clinical Trial Update: Safety and Efficacy of Telapristone Acetate (Proellex®) in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and efficacy of Telapristone Acetate (Proellex) for symptomatic endometriosis in pre-menopausal women; study completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Proellex (telapristone acetate)
• Telapristone Acetate (telapristone acetate)

Snippet

Sponsor: Repros Therapeutics Inc. | Conditions: Endometriosis | Phase 2 | Status: COMPLETED | Results posted: 2019-07-23